← ANALYST RATINGS · TIPRANKS
Avantor (AVTR): analyst forecast and price target
Analyst consensus
Hold0 Buy9 Hold1 Sell
Ratings of 10 analysts in the last 3 months · top analysts only12-month forecast
Based on 10 price targets given in the last 3 months, the average target is $14.83, the highest $17.00, the lowest $13.00. The average is −9.7% from the last price of $16.42.
Analyst ratings 20
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $12.00 → $15.00+25.0% | Hold | −8.6% | Reiterated | 16.10.26on TipRanks Oct 17 08:14 | +3.2% | ↗ |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $15.00 → $17.00+13.3% | Hold | +3.5% | Reiterated | 13.10.26on TipRanks 08:41 | +0.4%next day +2.0% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $14.00 → $15.00+7.1% | Hold | −8.6% | Assigned | 12.10.26on TipRanks 09:30 | −1.1%next day +0.4% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $15.50 | Hold | −5.6% | Reiterated | 12.10.26on TipRanks 06:30 | −1.1%next day +0.4% | ↗ |
| Lu Li★★★★★★★★★★#5185 · hits 80% · avg +11.8% | UBS | $14.40 → $17.00+18.1% | Hold | +3.5% | Reiterated | 09.10.26on TipRanks Oct 11 09:55 | +1.2%next day −1.1% · 5 days +6.8% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $13.00 → $15.00+15.4% | Sell | −8.6% | Reiterated | 07.10.26on TipRanks 03:55 | −0.3%next day +0.7% · 5 days +3.3% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $16.50 | Hold | +0.5% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $16.50 | Hold | +0.5% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $16.50 | Hold | +0.5% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $16.50 | Hold | +0.5% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $15.50 → $16.00+3.2% | Hold | −2.6% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $16.00 | Hold | −2.6% | Reiterated | 21.09.26on TipRanks 17:05 | — | |
| Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% | William Blair | — | Hold | — | Reiterated | 21.09.26on TipRanks 10:45 | −4.3%next day −1.0% · 5 days +2.3% | ↗ |
| Unknown Analyst | UBS | $10.50 → $16.00+52.4% | Hold | −2.6% | Initiated | 08.09.26on TipRanks Sep 9 06:50 | +2.4%next day −2.0% · 5 days +2.4% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $10.50 → $14.00+33.3% | Hold | −14.7% | Reiterated | 30.07.26on TipRanks 08:45 | −5.3%next day −1.3% · 5 days −8.5% | ↗ |
| Justin Bowers★★★★★★★★★★#8679 · hits 47% · avg 0.0% | Deutsche Bank | $11.00 → $13.00+18.2% | Hold | −20.8% | Reiterated | 30.07.26on TipRanks 08:31 | −5.3%next day −1.3% · 5 days −8.5% | ↗ |
| Daniel Arias★★★★★★★★★★#1848 · hits 50% · avg +8.0% | Stifel Nicolaus | $8.00 → $15.00+87.5% | Hold | −8.6% | Assigned | 30.07.26on TipRanks 07:26 | −5.3%next day −1.3% · 5 days −8.5% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $9.00 → $14.00+55.6% | Hold | −14.7% | Reiterated | 29.07.26on TipRanks Jul 30 07:02 | +17.3%next day −5.3% · 5 days −12.6% | ↗ |
| Tycho Peterson★★★★★★★★★★#1097 · hits 57% · avg +9.8% | Jefferies | $7.00 → $13.00+85.7% | Hold | −20.8% | Upgrade | 29.07.26on TipRanks 17:42 | −5.3%next day −1.3% · 5 days −8.5% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $9.00 → $11.00+22.2% | Hold | −33.0% | Reiterated | 08.07.26on TipRanks 06:50 | −4.0%next day +6.8% · 5 days +13.5% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | $7.00 | Sell | −57.4% | Assigned | 01.06.26on TipRanks 16:15 | −2.3%next day +1.6% · 5 days +13.2% | ↗ |
| Brandon Couillard★★★★★★★★★★#287 · hits 63% · avg +18.4% | Wells Fargo | $16.00 → $14.00−12.5% | Buy | −14.7% | Reiterated | 13.02.26on TipRanks 11:40 | +0.6%next day −1.8% · 5 days −3.5% | ↗ |
| Catherine Ramsey Schulte★★★★★★★★★★#864 · hits 53% · avg +11.2% | Robert W. Baird | $15.00 → $11.00−26.7% | Buy | −33.0% | Reiterated | 12.02.26on TipRanks 07:45 | −3.6%next day +0.6% · 5 days −2.4% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $13.00 → $11.00−15.4% | Hold | −33.0% | Reiterated | 11.02.26on TipRanks 14:10 | −13.6%next day −3.6% · 5 days −3.4% | ↗ |
| Unknown Analyst | Nephron | $8.00 | Sell | −51.3% | Downgrade | 11.12.25on TipRanks 07:35 | −0.6%next day −1.5% · 5 days −1.6% | ↗ |
| Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% | Raymond James | — | Hold | — | Downgrade | 04.11.25on TipRanks 05:05 | +0.3%next day −0.3% · 5 days −1.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Avantor
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 07.10.26: target $13.96 at a price of $15.43 (−9.5%); now: $14.96 at $16.42 (−8.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 9 | 10 | 14 | 13 | 15 | 7 |
| Sell | 3 | 4 | 3 | 3 | 1 | 1 |
Earnings and sales forecast
Next report: 28.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.21 (from $0.20 to $0.21). Last quarter: $0.21.
Sales
Next quarter’s sales estimate — $1.6B (from $1.6B to $1.7B). Last quarter: $1.7B.
Best top-analyst consensus in the sector · Healthcare
About Avantor
- CEO: Emmanuel Ligner
- Employees: 13,500
- Radnor Corporate Center, Radnor, PA, 19087, US
- www.avantorsciences.com
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Data from the stock’s TipRanks forecast page, read 7 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗